Novavax (NVAX) Acquisitions (2013 - 2020)
Novavax (NVAX) posted quarterly Acquisitions of $1.3 million for Q4 2020, up 143.24% quarter-over-quarter from -$3.0 million in Q4 2013.
Novavax (NVAX) Acquisitions (2013 - 2020) Analysis & Trends
Novavax's Acquisitions history runs 2 years deep, the most recent figure standing at $1.3 million for Q4 2020.
- In Q4 2020, Acquisitions changed N/A year-over-year to $1.3 million; the TTM figure through Dec 2021 stood at $1.3 million (changed 0.0% YoY), while the FY2020 annual figure was $165.5 million, changed N/A from the prior year.
- Acquisitions for Q4 2020 stood at $1.3 million, up from -$3.0 million in the prior quarter.
- The five-year high for Acquisitions was $1.3 million in Q4 2020, with the low at $1.3 million in Q4 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Acquisitions (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Novavax | 1.33 Bn | 607.37 Mn | 42.45 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | 1.31 Mn |
| Dec 31, 2013 | -3.03 Mn |